Sean Fenske's profile photo

Sean Fenske

West Orange

Following the medtech industry and new innovations in it. My thoughts and opinions are my own.

Featured in: Favicon mpo-mag.com Favicon odtmag.com

Articles

  • 1 week ago | odtmag.com | Sean Fenske

    The global orthopedic implants market, valued at about $20 billion in 2023, is expected to grow at a compound annual growth rate of 4.8%, reaching about $26.5 billion by 2029.1Technology advances (e.g., software, additive manufacturing, automation, optical measurement systems, Internet of Things, artificial intelligence), new or expanding markets, and a more active senior population are contributing factors to the steady growth of the orthopedic implant market.

  • 1 week ago | odtmag.com | Sean Fenske

    Conferences offer fantastic opportunities to learn more about topics you may not have been actively seeking or weren’t even aware of the questions you should be asking. They also serve as a great introduction to experts with whom you may not have been familiar. Further, you benefit from questions other attendees ask that you weren’t even thinking of. Recently, that’s been the case for me with gaining insights on tariffs.

  • 1 week ago | odtmag.com | Sean Fenske

    Orthopedic devices are highly engineered marvels that restore mobility and improve the lives of millions of people each year. The journey from concept to realization is no easy accomplishment, oftentimes taking years to go from concept to market. At the heart of this journey is the iterative process of design optimization for manufacturability, where getting it wrong can significantly impact realization with delays, excessive costs, or worse, a device that may never reach the patient.

  • 1 week ago | odtmag.com | Sean Fenske

    In today’s dynamic orthopedic landscape, innovation is not just a competitive advantage—it’s a necessity. Companies across the industry are increasingly faced with a strategic decision: Should innovation be driven internally, where control and expertise are centralized, or externally, where speed and cost-efficiency often take the lead? This is the classic build vs. buy conundrum (Figure 1).

  • 1 week ago | odtmag.com | Sean Fenske

    There was a time not that long ago when being a successful orthopedic medical device company meant being excellent at manufacturing parts. You designed reliable products, ensured quality, managed inventory, and delivered at scale. That was the business, and for years, it worked. But the landscape is shifting quickly.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
337
Tweets
379
DMs Open
No
Sean Fenske
Sean Fenske @SeanFenske
25 May 20

RT @MPOmagazine: Today’s #medtech #outsourcing providers are more than just “hired help”; they serve as an extension of an OEM’s capabiliti…

Sean Fenske
Sean Fenske @SeanFenske
25 May 20

RT @ODTmagazine: Editor-in-chief @SeanFenske asks: What will happen in the second half of the year or Q4 when ORs are ramping up for a high…

Sean Fenske
Sean Fenske @SeanFenske
8 Jan 20

Who turned out the lights at #digitalhealthces? Note taking is quite difficult now.